Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of extracellular vesicles in preparation of preparation for treating or preventing metabolic inflammatory syndrome diseases

A technology of vesicles and preparations, applied in the biological field, can solve problems such as time-consuming, high equipment requirements, and restrictions on the clinical transformation and application of exosome therapy

Pending Publication Date: 2022-01-25
EV CELL BIOTECH GUANGZHOU CO LTD
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are still many problems in the current exosome-based cell vesicle therapy, mainly in the complex and time-consuming process of exosome extraction and purification, high requirements for equipment and reagents, and low yield of physiological exosomes etc. These defects limit the clinical transformation and application of exosome therapy

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of extracellular vesicles in preparation of preparation for treating or preventing metabolic inflammatory syndrome diseases
  • Application of extracellular vesicles in preparation of preparation for treating or preventing metabolic inflammatory syndrome diseases
  • Application of extracellular vesicles in preparation of preparation for treating or preventing metabolic inflammatory syndrome diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0091] Example 1 Isolation and culture of BMMSCs

[0092] Excess CO was used according to the guidelines of the Animal Ethics Committee 2 Sacrifice the mice, remove the tibia and femur under aseptic conditions, peel off the muscles and connective tissue attached to them, further separate the metaphysis, expose the bone marrow cavity, and extract the volume fraction of 10% with a 10mL sterile syringe. The bone marrow cavity was washed repeatedly with PBS of fetal bovine serum, filtered through a cell strainer with a pore size of 70 μm, centrifuged at 500 g for 5 min, the supernatant was removed, and the cell pellet at the bottom was collected, resuspended in PBS, centrifuged at 500 g for 5 min again, and the final cell pellet was collected. Then, the cells were sorted by flow cytometry, and bone marrow mesenchymal stem cells (BMMSCs) were sorted out by using CD34- and CD90+ as sorting criteria. Finally, the cells were resuspended in Dex(-) medium and inoculated in a 10cm diame...

Embodiment 2

[0099] The acquisition of the IEVs of embodiment 2 BMMSC source

[0100] The MSCs (MSCs derived from bone marrow) cultured to the second generation in Example 1 were continued to be cultured with the medium (Dex(+) culture fluid) in Example 1 until the cells were confluent 80%-90%, washed with PBS for 2 Add serum-free medium containing 500nM STS (the medium is the medium in Example 1 with 500nM STS added), incubate at 37°C for 16-24h, collect the cell supernatant, and centrifuge at 800g for 10 hours at 4°C Minutes, the supernatant was collected and centrifuged at 2000g at 4°C for 10 minutes, and the supernatant was collected again and centrifuged at 16000g at 4°C for 30 minutes, and the obtained precipitate was IEVs. The pellet was resuspended in 500 μl of PBS, centrifuged again at 16,000 g for 30 minutes at 4°C, and the washed IEVs were obtained.

[0101] Preparation routes such as figure 2 shown.

Embodiment 3

[0105] The analysis of embodiment 3 IEVs

[0106] (1) Quantification of IEVs and analysis of membrane proteins

[0107] The IEVs obtained in Example 2 were quantitatively analyzed by flow cytometry, and the measurement time points were 1h, 4h, 8h, 16h and 24h, and the results showed that 106 MSCs were induced to 1h, 4h, 24h After 8h, 16h and 24h, 0.76×10 8 pcs, 1.29×10 8 pcs, 1.95×10 8 pcs, 2.48×10 8 pcs, 3.14×10 8 IEVs, it can be seen that after induction to 24h, a single MSC can produce 300 IEVs ( image 3 ).

[0108] The scattered light intensity of IEVs was analyzed by the standardized small particle microspheres (0.2 μm, 0.5 μm, 1 μm) produced by Bangs Laboratories, and the results showed that the particle diameters of IEVs were all below 0.2 μm ( Figure 4A ).

[0109] The results observed by transmission electron microscopy (TEM) are similar to those of flow cytometry, most of the vesicles have a diameter of 200nm or less ( Figure 4B ).

[0110] The results o...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Diameteraaaaaaaaaa
Diameteraaaaaaaaaa
Diameteraaaaaaaaaa
Login to View More

Abstract

The invention discloses application of extracellular vesicles in preparation of a preparation for treating or preventing metabolic inflammatory syndrome diseases. The metabolic inflammatory syndrome diseases comprise one or more of obesity, atherosclerosis and diabetes mellitus. The invention discloses a plurality of applications of induced extracellular vesicles from the aspects of appearance and mechanism. The invention also discloses application of an apoptosis vesicle detection reagent in preparation of an obesity detection reagent or kit.

Description

technical field [0001] The invention belongs to the field of biotechnology, and specifically relates to the application of extracellular vesicles in the preparation of preparations for treating or preventing metabolic inflammatory syndrome diseases. Background technique [0002] Extracellular vesicles (EVs) are nanoscale carriers secreted by cells that contain proteins, nucleic acids and various cytokines. Extracellular vesicles can act on target cells in an endocrine or paracrine manner, and play an important role in the process of intercellular material transfer and information exchange. Studies have found that the information exchange mediated by extracellular vesicles plays an important regulatory role in the physiological or pathological processes of the body, involving immune regulation, tumor growth, angiogenesis, and damage repair. Current research in this field is mainly focused on exosomes. Exosomes are extracellular vesicles with a diameter of about 30-150 nm, w...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/02G01N33/569G01N33/68A61K35/28A61P3/04A61P9/10A61P3/10G01N15/14G01N15/02
CPCG01N33/5005G01N33/56966G01N33/6827A61K35/28A61P3/04A61P9/10A61P3/10G01N15/14G01N15/0205G01N15/02G01N2800/044G01N2015/1486G01N2015/0238
Inventor 唐健霞寇晓星施松涛
Owner EV CELL BIOTECH GUANGZHOU CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products